FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

1307811000001106: Cefadroxil 125mg/5ml oral suspension 60 ml (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-May 2006. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
22684501000001110 Cefadroxil 125mg/5ml oral suspension 60 ml (product) en Fully specified name Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module
22684601000001114 Cefadroxil 125mg/5ml oral suspension 60 ml en Synonym Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module

1 descendants. Search Descendants:

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Cefadroxil 125mg/5ml oral suspension 60 ml Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Cefadroxil 125mg/5ml oral suspension 60 ml Is a Virtual medicinal product pack true Inferred relationship Existential restriction modifier
Cefadroxil 125mg/5ml oral suspension 60 ml Is pack of Product containing precisely cefadroxil (as cefadroxil monohydrate) 25 milligram/1 milliliter conventional release oral suspension false Inferred relationship Existential restriction modifier
Cefadroxil 125mg/5ml oral suspension 60 ml Has active ingredient Cefadroxil monohydrate false Inferred relationship Existential restriction modifier
Cefadroxil 125mg/5ml oral suspension 60 ml VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Cefadroxil 125mg/5ml oral suspension 60 ml VMP non-availability indicator Available false Inferred relationship Existential restriction modifier
Cefadroxil 125mg/5ml oral suspension 60 ml Has manufactured dose form Conventional release oral suspension false Inferred relationship Existential restriction modifier
Cefadroxil 125mg/5ml oral suspension 60 ml Has VMP Product containing precisely cefadroxil (as cefadroxil monohydrate) 25 milligram/1 milliliter conventional release oral suspension true Inferred relationship Existential restriction modifier
Cefadroxil 125mg/5ml oral suspension 60 ml Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Cefadroxil true Inferred relationship Existential restriction modifier
Cefadroxil 125mg/5ml oral suspension 60 ml Has specific active ingredient Cefadroxil monohydrate true Inferred relationship Existential restriction modifier
Cefadroxil 125mg/5ml oral suspension 60 ml Has dispensed dose form Conventional release oral suspension true Inferred relationship Existential restriction modifier
Cefadroxil 125mg/5ml oral suspension 60 ml VMP non-availability indicator Not available true Inferred relationship Existential restriction modifier
Cefadroxil 125mg/5ml oral suspension 60 ml Has basis of strength substance Cefadroxil true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Baxan 125mg/5ml suspension (Bristol-Myers Squibb Pharmaceuticals Limited) 60 ml Is a True Cefadroxil 125mg/5ml oral suspension 60 ml Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start